Skip to content
Clinical Trials – home
Centre Hospitalier Universitaire Rouen
Sponsor

Centre Hospitalier Universitaire Rouen

France 1 Rue De Germont, Bp 96031, 76031 Rouen, France

About the sponsor

Clinical research includes pancreatic adenocarcinoma, colon cancer, and rectal cancer, with attention to perioperative treatment, postoperative recovery, and infection prevention in complex surgical settings.

  • Pancreatic cancer
  • Colon cancer
  • Rectal cancer
  • Postoperative infection prevention

Interest also extends to obstructive colon cancer, pancreaticoduodenectomy, and supportive strategies after colorectal and pancreatic surgery.

About Specializations

Centre Hospitalier Universitaire Rouen runs clinical trials in conditions such as Renal transplant, Colon cancer, Hypertension, Pain, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

24 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nefopam Hydrochloride
  • Sponsor:Centre Hospitalier Universitaire Rouen
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Belatacept
  • Sponsor:Centre Hospitalier Universitaire Rouen
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Centre Hospitalier Universitaire Rouen
Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Rotigotine
  • Sponsor:Centre Hospitalier Universitaire Rouen
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Centre Hospitalier Universitaire Rouen
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Valganciclovir
  • Sponsor:Centre Hospitalier Universitaire Rouen

Pemphigus

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Centre Hospitalier Universitaire Rouen
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sildenafil
  • Sponsor:Centre Hospitalier Universitaire Rouen
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Piperacillin
  • Sponsor:Centre Hospitalier Universitaire Rouen
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Domperidone
  • Sponsor:Centre Hospitalier Universitaire Rouen
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Adipose Tissue-Derived Stromal Vascular Fraction
  • Sponsor:Centre Hospitalier Universitaire Rouen

Colon cancer+1

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Centre Hospitalier Universitaire Rouen

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).